Literature DB >> 30406756

Location location location: an exploration of disparities in access to publicly listed pre-exposure prophylaxis clinics in the United States.

Aaron J Siegler1, Anna Bratcher2, Kevin M Weiss2, Farah Mouhanna2, Lauren Ahlschlager2, Patrick S Sullivan2.   

Abstract

PURPOSE: HIV pre-exposure prophylaxis (PrEP) is highly effective in preventing HIV transmission. Finding a PrEP provider, however, can be a barrier to accessing care. This study explores the distribution of publicly listed PrEP-providing clinics in the United States.
METHODS: Data regarding 2094 PrEP-providing clinics come from PrEP Locator, a national database of PrEP-providing clinics. We compared the distribution of these PrEP clinics to the distribution of new HIV diagnoses within various geographical areas and by key populations.
RESULTS: Most (43/50) states had less than one PrEP-providing clinic per 100,000 population. Among states, the median was two clinics per 1000 PrEP-eligible men who have sex with men. Differences between disease burden and service provision were seen for counties with higher proportions of their residents living in poverty, lacking health insurance, identifying as African American, or identifying as Hispanic/Latino. The Southern region accounted for over half of all new HIV diagnoses but only one-quarter of PrEP-providing clinics.
CONCLUSIONS: The current number of PrEP-providing clinics is not sufficient to meet needs. In addition, PrEP-providing clinics are unevenly distributed compared to disease burden, with poor coverage in the Southern divisions and areas with higher poverty, uninsured, and larger minority populations. PrEP services should be expanded and targeted to address disparities.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIV; Pre-exposure prophylaxis; Primary prevention

Mesh:

Substances:

Year:  2018        PMID: 30406756      PMCID: PMC6261794          DOI: 10.1016/j.annepidem.2018.05.006

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  27 in total

1.  A Clinical Home for Preexposure Prophylaxis: Diverse Health Care Providers' Perspectives on the "Purview Paradox".

Authors:  Susie Hoffman; John A Guidry; Kate L Collier; Joanne E Mantell; Daria Boccher-Lattimore; Farnaz Kaighobadi; Theo G M Sandfort
Journal:  J Int Assoc Provid AIDS Care       Date:  2015-08-20

Review 2.  Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings.

Authors:  Julia L Marcus; Jonathan E Volk; Jess Pinder; Albert Y Liu; Oliver Bacon; C Bradley Hare; Stephanie E Cohen
Journal:  Curr HIV/AIDS Rep       Date:  2016-04       Impact factor: 5.071

3.  Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation.

Authors:  Julia L Marcus; Leo B Hurley; Charles Bradley Hare; Dong Phuong Nguyen; Tony Phengrasamy; Michael J Silverberg; Juliet E Stoltey; Jonathan E Volk
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-15       Impact factor: 3.731

Review 4.  Traveling towards disease: transportation barriers to health care access.

Authors:  Samina T Syed; Ben S Gerber; Lisa K Sharp
Journal:  J Community Health       Date:  2013-10

5.  HIV Preexposure Prophylaxis Implementation at Local Health Departments: A Statewide Assessment of Activities and Barriers.

Authors:  Helen L Zhang; Sarah K Rhea; Christopher B Hurt; Victoria L Mobley; Heidi Swygard; Arlene C Seña; Mehri S McKellar
Journal:  J Acquir Immune Defic Syndr       Date:  2018-01-01       Impact factor: 3.731

6.  HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study.

Authors:  Douglas Krakower; Norma Ware; Jennifer A Mitty; Kevin Maloney; Kenneth H Mayer
Journal:  AIDS Behav       Date:  2014-09

7.  The impact of patient race on clinical decisions related to prescribing HIV pre-exposure prophylaxis (PrEP): assumptions about sexual risk compensation and implications for access.

Authors:  Sarah K Calabrese; Valerie A Earnshaw; Kristen Underhill; Nathan B Hansen; John F Dovidio
Journal:  AIDS Behav       Date:  2014-02

8.  Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015.

Authors:  Dawn K Smith; Michelle Van Handel; Richard J Wolitski; Jo Ellen Stryker; H Irene Hall; Joseph Prejean; Linda J Koenig; Linda A Valleroy
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-11-27       Impact factor: 17.586

9.  Developing a Web-Based Geolocated Directory of HIV Pre-Exposure Prophylaxis-Providing Clinics: The PrEP Locator Protocol and Operating Procedures.

Authors:  Aaron J Siegler; Susan Wirtz; Shannon Weber; Patrick S Sullivan
Journal:  JMIR Public Health Surveill       Date:  2017-09-06

10.  Estimating the population size of men who have sex with men in the United States to obtain HIV and syphilis rates.

Authors:  David W Purcell; Christopher H Johnson; Amy Lansky; Joseph Prejean; Renee Stein; Paul Denning; Zaneta Gau; Hillard Weinstock; John Su; Nicole Crepaz
Journal:  Open AIDS J       Date:  2012-09-07
View more
  40 in total

1.  Demographic, Behavioral, and Geographic Differences Between Men, Transmen, and Transwomen Currently on PrEP, Former PrEP Users, and Those Having Never Used PrEP.

Authors:  Drew A Westmoreland; David W Pantalone; Viraj V Patel; Donald Hoover; Denis Nash; Christian Grov
Journal:  AIDS Behav       Date:  2020-05

2.  PrEP Implementation and Persistence in a County Health Department Setting in Atlanta, GA.

Authors:  Charlotte-Paige Rolle; Udodirim Onwubiko; Jennifer Jo; Anandi N Sheth; Colleen F Kelley; David P Holland
Journal:  AIDS Behav       Date:  2019-10

3.  Accessing Pre-exposure Prophylaxis (PrEP): Perceptions of Current and Potential PrEP Users in Birmingham, Alabama.

Authors:  Whitney S Rice; Kristi L Stringer; Maira Sohail; Kaylee B Crockett; Ghislaine C Atkins; Kachina Kudroff; D Scott Batey; Joshua Hicks; Janet M Turan; Michael J Mugavero; Bulent Turan
Journal:  AIDS Behav       Date:  2019-11

Review 4.  Telemedicine: a solution to disparities in human immunodeficiency virus prevention and pre-exposure prophylaxis uptake, and a framework to scalability and equity.

Authors:  Keith Yiu Kei Wong; Chrysovalantis Stafylis; Jeffrey D Klausner
Journal:  Mhealth       Date:  2020-04-05

5.  HIV Pre-Exposure Prophylaxis Implementation Cascade Among Health Care Professionals in the United States: Implications from a Systematic Review and Meta-Analysis.

Authors:  Chen Zhang; James McMahon; Kevin Fiscella; Sarahmona Przybyla; Amy Braksmajer; Natalie LeBlanc; Yu Liu
Journal:  AIDS Patient Care STDS       Date:  2019-12       Impact factor: 5.078

Review 6.  Review of Real-World Implementation Data on Emtricitabine-Tenofovir Disoproxil Fumarate as HIV Pre-exposure Prophylaxis in the United States.

Authors:  Jessica L Adams; Karishma Shelley; Melanie R Nicol
Journal:  Pharmacotherapy       Date:  2019-04-01       Impact factor: 4.705

7.  Geospatial perspectives on health: The PrEP4Love campaign and the role of local context in health promotion messaging.

Authors:  Gregory Phillips Ii; David J McCuskey; Dylan Felt; Anand B Raman; Christina S Hayford; Jim Pickett; Julia Shenkman; Peter T Lindeman; Brian Mustanski
Journal:  Soc Sci Med       Date:  2020-11-04       Impact factor: 4.634

Review 8.  PrEP Product Acceptability and Dual Process Decision-Making Among Men Who Have Sex with Men.

Authors:  José A Bauermeister; Julie S Downs; Douglas S Krakower
Journal:  Curr HIV/AIDS Rep       Date:  2020-06       Impact factor: 5.071

9.  Perspectives and Recommendations From Lesbian, Gay, Bisexual, Transgender, and Queer/Questioning Youth of Color Regarding Engagement in Biomedical HIV Prevention.

Authors:  Sarit A Golub; Kathrine Meyers; Chibuzo Enemchukwu
Journal:  J Adolesc Health       Date:  2019-11-25       Impact factor: 5.012

10.  Policy- and county-level associations with HIV pre-exposure prophylaxis use, the United States, 2018.

Authors:  Aaron J Siegler; C Christina Mehta; Farah Mouhanna; Robertino Mera Giler; Amanda Castel; Elizabeth Pembleton; Chandni Jaggi; Jeb Jones; Michael R Kramer; Pema McGuinness; Scott McCallister; Patrick S Sullivan
Journal:  Ann Epidemiol       Date:  2020-04-03       Impact factor: 3.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.